Navigation Links
Lilly Announces Termination of AIR Insulin Program
Date:3/7/2008

INDIANAPOLIS, March 7 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced the termination of development of its AIR(R) Insulin program, which was being conducted in partnership with Alkermes, Inc. The program has been in phase III clinical development as a potential treatment for type 1 and type 2 diabetes. The company noted that this decision is not a result of any observations during AIR Insulin trials relating to the safety of the product, but rather was a result of increasing uncertainties in the regulatory environment, and a thorough evaluation of the evolving commercial and clinical potential of the product compared to existing medical therapies.

"This decision, though difficult, is the right one to make at this time," commented John Lechleiter, Ph.D., Lilly president and chief operating officer. "Over the past several months we have conducted a thorough review of all aspects of our efforts to develop our AIR Insulin product and have now made the decision that it would be inappropriate for the company to continue development activities in connection with this project. Without the prospect of a new drug application, keeping the patient foremost in mind, it would not be consistent with our medical principles to continue the clinical trials. As a result, we are now beginning the process of halting our ongoing clinical studies and transitioning the AIR Insulin patients in these studies to other appropriate therapies. We wish to reassure patients currently receiving AIR Insulin in our ongoing clinical trials that they should have no health or safety concerns about continuing to use AIR Insulin during their transition to other well-established diabetes therapies."

Steven M. Paul, M.D., executive vice p
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2010)... Medivation, Inc. (Nasdaq: MDVN ) today announced that it will host a ... provide a general business update on March 15, 2010 , at 4:30 p.m. ... December 31, 2009 will be released after markets close on March 15, 2010 ... ... ...
(Date:3/11/2010)... a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1).  Additional claims ... ... , ... ... ...
(Date:3/11/2010)... 11 Stem Cell Assurance, Inc. ... to announce the inclusion of one of the Cleveland ... , M.D., F.A.C.S.  Dr. Ross will officially take up ... .  Stem Cell Assurance welcomes his appointment to strengthen ... medical and cosmetic procedures and cell banking to individual ...
(Date:3/11/2010)... ... , , ... ... ... EDMONTON , March 11 /PRNewswire/ - Today at ACAMP,s latest seminar, Alberta,s conventional energy industry learned how nanotechnology, micro-systems and micro-fluidics ...
Breaking Biology Technology:Medivation Announces Fourth Quarter and Year-End 2009 Financial Results Teleconference and Webcast On March 15, 2010 2Medivation Announces Fourth Quarter and Year-End 2009 Financial Results Teleconference and Webcast On March 15, 2010 3Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 2Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 3Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 2Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 3Joseph J. Ross, M.D., F.A.C.S. Joins Stem Cell Assurance as Vice Chairman 4Alberta companies delivering new products to the Conventional Energy marketplace 2Alberta companies delivering new products to the Conventional Energy marketplace 3
... accountability is the way of life at Meriter ... that provides medical care to southern Wisconsin. Meriter includes ... home health care service. Formed from a merger of ... includes more than 430 active and associate physicians in ...
... The state Department of Commerce is asking ... center that would help entrepreneurs develop and sell technology products. ... for the center, which Gov. Jim Doyle authorized this ... $1 million annually, officials said. , ,Gov. Jim Doyle is ...
... multimedia resources on children's books including audio of book ... on a Wisconsin Department of Public Instruction site ... is a new service of BadgerLink , which ... other resources to Wisconsin schools, libraries and homes. , ,Madison ...
Other Biology Technology:Meriter IT team builds project performance through internal relationships 2Meriter IT team builds project performance through internal relationships 3Meriter IT team builds project performance through internal relationships 4TeachingBooks brings free K-12 resources to Wisconsin residents 2
(Date:3/12/2010)... a vital factor in modern viticulture, due to the ... wine quality and the environmental impact of agricultural practices ... area, the NEIKER-Tecnalia technological centre is carrying out research ... irrigation regimes for the typical flat and sloping soils ... grape and wine quality. The initial results when cover ...
(Date:3/11/2010)... of Minnesota have created a molecular image of a ... achievement is a breakthrough for biology and could provide ... nanoscale devices to moving electricity around the country. , ... professor in the College of Biological Sciences, is published ... , "Evolution has been fine-tuning electricity in ...
(Date:3/11/2010)... gun to better manage their disease by controlling their ... sticky wicket of needing treatment that makes them hungry, ... levels and prevent weight gain may suggest an eating ... blame, said Dr. Deborah Young-Hyman, pediatric psychologist at the ... "You can,t use the same criteria to diagnose eating ...
Breaking Biology News(10 mins):The use of cover crops in vineyards can help control the yield and quality of grapes and wine 2The use of cover crops in vineyards can help control the yield and quality of grapes and wine 3U of Minnesota researcher discovers how electricity moves through cells 2Diabetes' link to eating disorders explored 2Diabetes' link to eating disorders explored 3Three Cetaphil 28R 29 Products Earn Good Housekeeping Seal 5554 1Three Cetaphil 28R 29 Products Earn Good Housekeeping Seal 5554 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 1National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 3National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 1PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 2PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 3PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 4PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 5
... using glow-in-the-dark proteins and microcinematography, have helped unravel ... in the bacterium that causes "walking pneumonia." , ... the unique cell extension that forms on one ... called a "terminal organelle," performs several tasks for ...
... Colloids and Interfaces have presented a new method with ... the salt content and the temperature of the solution. ... theoretical model which exactly describes the processes in the ... is possible to predict, without any experimental investigations, how ...
... the healing wisdom of Pacific Island cultures by testing ... Dutch herbal text for its anti-bacterial properties. Early results ... bacteria that can cause diarrhea, as claimed by naturalist ... healing methods in the book Ambonese Herbal. , The ...
Other Biology News:UGA scientists unravel 'molecular inch-worm' structure of walking-pneumonia bacterium 2Microcapsules like it hot and salty 2Microcapsules like it hot and salty 3Mayo Clinic collaboration mining of ancient herbal text leads to potential new anti-bacterial drug 2
... Situ Assay Kit is a fluorescent-based assay ... undergoing apoptosis. The kit is for research ... or therapeutic procedures. CHEMICON®s CaspaTag™ Pan-Caspase In ... to detect active caspases. The methodology is ...
... jetSI 10 nM is available for ... as described in: Z. Hassani, G.-F. Lemkine, ... Behr, and B.-A. Demeneix. Lipid-mediated siRNA delivery ... mouse brain at picomolar levels. J. Gene ...
... new-generation siRNA transfection reagent that achieves over ... siRNA in a wide variety of adherent ... Using low siRNA concentrations avoids unwanted toxic ... siRNA at higher concentrations, thereby allowing accurate ...
... The IHC Select Immunoperoxidase Secondary Detection System ... or goat IgG in the Primary Antibody. ... present in the specimen. Any excess antibody ... Antibody Reagent (conjugated to biotin) is added ...
Biology Products: